In our recent report, we found that SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via the β-catenin pathway [16] and that SLFN5 can affect the epithelial morphology of breast cancer cells by downregulating the transcription of ZEB1 [17]. The gene discussed is SLFN5; the disease is breast carcinoma.